Why Q BioMed
Through Q BioMed investors have the opportunity to invest in some of the most innovative bio-medical products that they may never have known about.
Technologies are vetted by analysts, industry KOLs and experts.
Your investment is in Q BioMed – so you have public company liquidity without being tied up in a private company with an unknown exit strategy and uncertain value inflection milestones (FDA etc).
Q BioMed aims to mitigate risk by having multiple relationships and assets across a broad spectrum of healthcare companies and sectors.
Success being shared as multiple assets mature at different times in their development cycle passing on value to the Q BioMed shareholders.